Influence of statin therapy on antiphospholipid antibodies and endothelial dysfunction in young patients with coronary artery disease and systemic lupus erythematosus

Influence of statin therapy on antiphospholipid antibodies and endothelial dysfunction in young patients with coronary artery disease and systemic lupus erythematosus

Introduction Antiphospholipid antibodies (aPL) affect atherogenesis and may cause thromboembolism in systemic lupus erythematosus (SLE) and coronary artery disease (CAD). Intensive treatment with statins may reduce inflammation and decrease the number of thrombotic events. That may explain the benef...

Full description

Bibliographic Details
Main Authors: Adam Mazurek, Krzysztof Gryga, Kamil Bugala, Teresa Iwaniec, Jacek Musial, Piotr Podolec, Wojciech Plazak
Format: Article
Language:English
Published: Termedia Publishing House 2020-02-01
Series:Archives of Medical Science
Subjects:
rheumatic diseases
atherosclerosis
antiphospholipid syndrome
myocardial ischemia
Online Access:https://www.archivesofmedicalscience.com/Influence-of-statin-therapy-on-antiphospholipid-antibodies-and-endothelial-dysfunction,103865,0,2.html

Internet

https://www.archivesofmedicalscience.com/Influence-of-statin-therapy-on-antiphospholipid-antibodies-and-endothelial-dysfunction,103865,0,2.html

Similar Items